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Sprouting angiogenesis, crucial for the development
of newblood vessels, is a prime example of collective
migration in which endothelial cells migrate as a
group joined via cadherin-containing adherens junc-
tions (AJ). The actomyosin apparatus is connected
to AJ and generates contractile forces, which, de-
pending on their strength and duration, increase or
decrease cell cohesion. Thus, appropriate spatio-
temporal control of junctional myosin is critical, but
the mechanisms underlying it are incompletely
understood. We show that Raf-1 is an essential
component of this regulatory network and that its
ablation impairs endothelial cell cohesion, sprouting,
and tumor-induced angiogenesis. Mechanistically,
Raf-1 is recruited to VE-cadherin complexes by
a mechanism involving the small G protein Rap1
and is required to bring the Rho effector Rok-a to
nascent AJs. This Raf-1-mediated fine tuning of
Rok-a signaling allows the activation of junctional
myosin and the timely maturation of AJ essential
for maintaining cell cohesion during sprouting angio-
genesis.
INTRODUCTION
Angiogenesis is a complex process involving the migration and
proliferation of endothelial cells (ECs) and their incorporation
into new blood vessels. During embryonic life, this process is
essential for cardiovascular development. In the adult, angio-
genesis is crucial for tissue regeneration, for the establishment
of chronic inflammatory conditions, and, most notably, for tumor
development. Angiogenesis ensures the supply of nutrients and
oxygen to the growing tumor, which expresses pro-angiogenic
proteins, such as VEGF, FGF-2, TGF-b, and others to recruit
vascular ECs from neighboring blood vessels (Chung et al.,
2010). During this process, called sprouting angiogenesis, ECs
must coordinate two programs: one that allows the emergence
of tip cells, which detach from the existing vessels and migrate
following guidance cues, providing directionality to the devel-
oping vessel network; and a program that supports the growth158 Developmental Cell 22, 158–171, January 17, 2012 ª2012 Elseviof the sprout by stabilizing the contacts between the tip and
the stalk cells, which form the stem of the developing sprout
(Eilken and Adams, 2010). Both programs crucially depend on
dynamic changes in cell cohesion and on the remodeling of
the cytoskeleton.
In ECs, as well as in epithelial cells, initial cell-cell contacts
involve the adherens junctions (AJ), in which adhesion is medi-
ated by homophilic interaction of classical cadherin molecules
expressed by neighboring cells (VE-cadherin in endothelial,
E-cadherin in epithelial cells). The extracellular cadherin domains
initiate contact, whereas the cytoplasmic tails bind to proteins
that anchor the junctions to the actin cytoskeleton. The formation
of cadherin clusters and their interaction with the cytoskeleton,
particularly with the actomyosin contractile apparatus, allow
the maturation of the cell-cell contacts; at the same time, the
connection with actomyosin allows the junctions to sense and
respond to mechanical stress (Dejana et al., 2009; Liu et al.,
2010; Papusheva and Heisenberg, 2010). The small GTPases
Rap, Rac, and Rho regulate AJ dynamics during the formation
of both epithelial and endothelial cell-cell contacts (Cascone
et al., 2003; Dejana et al., 2009; Kooistra et al., 2007; Liu et al.,
2010; Pannekoek et al., 2009; Yamada and Nelson, 2007);
however, the precise molecular mechanisms mediating the
generation and spatial control of contractile forces at the AJ
are not yet understood completely.
In ECs, cell-cell contact and VE-cadherin (VEC) antagonize
angiogenic sprouting by restraining VEGF-induced proliferation
(Grazia Lampugnani et al., 2003; Lampugnani et al., 2006);
VEGF, in turn, might counteract cell-cell contact formation by
inducing VEC endocytosis (Gavard and Gutkind, 2006). In
addition, VEC restrains tubulogenesis and sprout formation in
zebrafish and in three-dimensional (3D) human umbilical vein
endothelial cells (HUVECs) cultures through a mechanism
involving the phosphorylation of myosin light chain 2 (MLC2)
mediated by the Rho effector kinase Rok (Abraham et al.,
2009). Rok activity and phosphorylation of cortical MLC limit
the protrusional activity of tip cells and branching (Fischer
et al., 2009); on the other hand, Rho activity is necessary for
the assembly of ECs in new vessels in vivo (Hoang et al.,
2004). Thus, a tight control of Rho downstream pathways is
crucial for successful angiogenesis.
Raf-1, a member of the Raf family of protein kinases (A-Raf,
B-Raf, and Raf-1, also known as C-Raf) linking Ras activation
to the ERK pathway, has been previously implicated in angio-
genesis. In ECs, activation of Raf-1 by VEGFA and FGF-2er Inc.
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respectively (Alavi et al., 2003; Alavi et al., 2007; Hood et al.,
2002). In the past few years, gene ablation studies have high-
lighted other ERK-independent essential functions of Raf-1,
such as promotingmigration and protecting cells from apoptosis
(Ehrenreiter et al., 2005;Mikula et al., 2001; Piazzolla et al., 2005).
These functions do not require Raf-1 kinase activity and are
based on Raf-1’s ability to interact with, and inhibit, the proapo-
ptotic kinases ASK-1 and MST2, as well as Rok-a (Baccarini,
2005; Niault et al., 2009). The Raf-1/Rok-a interaction is also
essential for the development and maintenance of Ras-driven
epidermal tumors (Ehrenreiter et al., 2009).
Here, we show that Raf-1 is required for the establishment of
tumor-associated vasculature in vivo and for sprouting in 3D
EC cultures. In Raf-1-deficient ECs, the formation of AJ and
their coupling to actomyosin contractility is delayed; mechanis-
tically, Raf-1 is recruited to VEC-containing AJ by a mechanism
involving the small G protein Rap1, and this step is required
for the localization of the Rok-a to the AJ and for the timely
phosphorylation of MLC2 in these structures. These data
demonstrate a crucial role of the Raf-1/Rok-a complex in the
generation of spatially controlled actomyosin activity during the
formation of VEC-containing AJ.
RESULTS
Raf-1 Is Required for Sprouting of Primary ECs in 3D
Cultures and for Pathological Angiogenesis In Vivo
Ablation of the c-raf-1 gene in ECs was achieved by combin-
ing the Tie2-Cre transgene (Forde et al., 2002) with a homozy-
gous c-raf-1f/f allele (Jesenberger et al., 2001). These mice
(c-raf-1D/DEC, deleted in ECs) were born at mendelian ratios
(see Supplemental Experimental Procedures available online)
and exhibited a normal life span. Raf-1 ablation was confirmed
by the analysis of primary microvessel-derived mouse ECs
(pMECs) isolated from the lung of Raf-1D/DEC animals, which
showed complete conversion of the c-raf-1flox to the c-raf-1D
allele by PCR and did not express the Raf-1 protein (see Supple-
mental Experimental Procedures). The blood vessel structure
and tissue architecture of Raf-1D/DEC and f/f kidneys, lungs,
and livers was indistinguishable (Figure S1A). In contrast, anal-
ysis of the developing retinal vasculature on postnatal day 6
revealed a delay in the progression of the angiogenic front
toward the periphery (Figure S1B). Branching was also compro-
mised (Figure S1C), and the Raf-1D/DEC angiogenic front
contained increased numbers of tip cells extending filopodia
and thus acquiring a motile, exploratory phenotype (Figure S1D).
Mitotic and apoptotic indexes were comparable in the f/f and
Raf-1D/DEC retinas, and the knockout did not influence vessel
stability (data not shown). Together, the data suggest that Raf-
1 ablation impacts collective, but not single cell migration in vivo.
Consistent with these in vivo data, Raf-1D/D EC migrated slightly
faster than f/f cells in a transwell assay (Figure S1F), proliferated
normally, and did not show increased apoptosis (data not
shown) in conventional two-dimensional (2D) culture systems.
In addition, ERK phosphorylation levels were similar or higher in
continuously growing or FGF-2-stimulated Raf-1D/D ECs than in
f/f ECs (Figures S1G and S2G). In contrast to this inconspicuous
behavior in 2D cultures, Raf-1D/D pMECs showed severe defectsDevelopmin angiogenesis assays in 3D cultures. Aorta explants from
Raf-1D/DEC mice showed dramatically reduced sprouting into
fibrin gels (Figure S2A). Yet more compelling were the results
obtained by testing the ability of pMECs cultured onmicrocarrier
beads to form sprouts in fibrin gels, an assay that recapitulates
the salient steps of sprouting: migration, proliferation, alignment,
and tube formation (Nakatsu et al., 2007) (Figure S2B). While f/f
pMECs migrated out of the beads and formed complex
tubular networks within 3 days, the number and length of sprouts
formed by Raf-1D/Dwas dramatically reduced (Figure 1A). Impor-
tantly, Raf-1D/D pMECs adhered to the microcarrier and prolifer-
ated as efficiently as f/f pMECs (Figures S2C and S2D). They
were able to assume a mesenchymal morphology, reminiscent
of the excess tip cells observed in the developing retina, and to
efficiently migrate out of the beads (Figures 1B and 1C; Fig-
ure S2E). Video microscopy revealed that f/f cells aligned and
remained connected during sprout formation. In Raf-1D/D
pMEC cultures, in contrast, the tip cells broke off from the devel-
oping tubule, migrating further in the fibrin gel, and finally under-
going membrane blebbing and apoptosis (Figure 1B; Movies S1
and S2).
To determine whether these sprouting defects had a counter-
part in the adult animal, we investigated neovascularization
by subcutaneously injecting f/f and Raf-1D/DEC mice with FGF-
2/VEGF-supplemented matrigel. The numbers of proliferating
and apoptotic ECs in plugs isolated from control and Raf-1D/DEC
mice 10 days after injection were similar (Figures S2F and S2G);
however, plugs harvested from Raf-1D/DEC mice were much less
vascularized (Figures 1D and 1E), and the few vessels were
restricted to the edges of the plug (Figure 1D). In addition, subcu-
taneously grafted Lewis lung carcinoma (LLC-1) cells grew
poorly in Raf-1D/DEC mice, and the vascular density in the grafts
was greatly reduced (Figures 1F and 1G). Thus, the presence of
Raf-1 in ECs is necessary for pathological angiogenesis.
Raf-1 Is Required for the Establishment
of VEC-Containing AJ
The sprouting phenotype of Raf-1D/D pMECswas consistent with
a defect in cell-cell adhesion, which depends on VEC (Abraham
et al., 2009). VEC expression (Figure 2A) andmembrane localiza-
tion (see Supplemental Experimental Procedures) were similar in
confluent 2D f/f and Raf-1D/D MECs monolayers. In 3D cultures,
however, VE-cadherinwasdiffusely localized inRaf-1D/DpMECs,
even in those forming sprouts, in contrast to flox/flox cells, in
which this molecule was clearly concentrated in AJ (Figure 2B).
VE-cadherin mislocalization could also be observed in vivo, in
the Raf-1D/DEC sprouts invading matrigel plugs (Figure 2C), and
in the tip cells of Raf-1D/DEC retinas (Figure S1E).
Analysis of AJ formation after replating in 2D cultures showed
that VEC-containing junctions appeared, spread, and matured
with considerable delay in immortalized Raf-1D/D EC cultures
(iMECs; Figure 2D). Active myosin II, which mediates VEC local-
ization to cell-cell junctions and connects these structures to
the actomyosin system (Abraham et al., 2009), was detected
as phosphorylated MLC2 (pMLC2) in cell-cell contacts of f/f
iMECs. In contrast, less pMLC2 could be detected in the AJ
developing between Raf-1D/D MECs (Figure 2D), although the
total amount of pMLC2 was slightly increased in these cells (Fig-
ure 2A). As in HUVECs (Abraham et al., 2009), treatment with anental Cell 22, 158–171, January 17, 2012 ª2012 Elsevier Inc. 159
Figure 1. Raf-1 Is Required for In Vitro Sprouting in 3D Fibrin Gels and In Vivo for Pathological Angiogenesis
(A) pMECs isolated from Raf-1D/DEC animals show dramatically reduced sprouting in 3D fibrin gels. pMECs were allowed to adhere to microcarriers and
embedded in fibrin gels containing FGF-2 and VEGF (200 ng/ml each). The number of sprouts/bead and the length of sprouts weremicroscopically assessed after
3 days in culture. The results are plotted in the right panel. n = number of microcarriers evaluated; error bars, SD of the mean.
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junctional actomyosin activation (Figure 2D). In 3D pMEC
cultures, 10 mM of Y-27632 increased sprouting of control cells
(Abraham et al., 2009), but higher concentrations of the inhibitor
dramatically decreased it, phenocopying the sprouting defect
of Raf-1D/D pMECs (Figure 2E).
Raf-1 Is Required for the Recruitment of Rok-a to AJ
Raf-1 interacts with, and regulates, the MLC2 activator Rok-a
(Ehrenreiter et al., 2009; Ehrenreiter et al., 2005; Niault et al.,
2009; Piazzolla et al., 2005). Thus, a defect in Rok-a localization
or activity could underlie the diffused VEC staining and the lack
of pMLC2 observed in the developing Raf-1D/D AJ. As in other
cell types (Ehrenreiter et al., 2009; Ehrenreiter et al., 2005; Niault
et al., 2009; Piazzolla et al., 2005), lack of Raf-1 in MECs did not
alter Rok-a expression, whereas a number of Rok-a downstream
targets, with the notable exception of junctional pMLC2, were
slightly hyperphosphorylated (Figures 2A and 2D).
To gain insight in the molecular mechanisms underlying the
phenotype of Raf-1D/D MECs, we analyzed VEC complexes.
Unexpectedly, VEC immunoprecipitates from f/f cells contained
low amounts of Raf-1, which reproducibly increased upon stimu-
lation of iMECs with VEGF (not significant) and FGF-2 (Figures 3A
and 3B). Rok-awas recruited to VECwith kinetics similar to Raf-1
(Figures 3B–3D). The fraction of Raf-1 and Rok-a binding to VEC
was higher in confluent than in sparse cultures, implying that AJ
are required for the interaction (Figure 3C). In Raf-1D/D iMECs,
however, the FGF-2- and VEGF-mediated recruitment of Rok-a
to VEC was abrogated, whereas the recruitment of b and p120
catenins was unperturbed (Figure 3D). Thus, Raf-1 is selectively
required for efficient growth factor-mediated recruitment of
Rok-a to AJ. Consistently, FGF-2 induced phosphorylation of
the Rok downstream effector MLC2 in both f/f and Raf-1D/D
iMECs, but in the latter cells, pMLC failed to localize to the cell-
cell contacts (Figure 3E). The appearance of junctional pMLC2
correlated with the colocalization of Rok-a with VEC at cell-cell
contacts (Figure 3F), also selectively lost in Raf-1D/D MECs.
Rok-b, in contrast, did not coimmunoprecipitate with VEC or
Raf-1anddidnot colocalizewithVECatAJ (FiguresS3AandS3B).
Importantly, loss of junctional pMLC could also be observed
in the short vessels invading the matrigel plugs implanted in
Raf-1D/DEC mice (Figure 3G). This is consistent with the mislocal-
ization of VEC observed in Raf-1D/DEC sprouts (Figure 2C) and
indicates that the molecular phenotype induced by Raf-1 abla-
tion is the same in vivo and in culture. Collectively, the results
show that Raf-1 is essential for bringing Rok-a to developing(B) Sprout formation monitored by time lapse microscopy. Still images taken at
single-tip cells break off from the developing sprouts,migrate as single cells (black
(green arrow).
(C) Raf-1D/D pMECs exhibit a mesenchymal phenotype during sprouting in fibr
structures.
(D and E) Raf-1D/DEC mice fail to vascularize subcutaneous matrigel plugs. Matrige
and Raf-1D/DEC mice. Ten days later, plugs were fixed and stained with anti-VEC
the outermargin of the plug. In (E), a quantification of CD31-positive vessels/field is
the mean.
(F and G) Raf-1 ablation impairs xenograft growth and vascularization. The gr
implantation of 106 Lewis lung carcinoma cells (LLC-1) into f/f and Raf-1D/DEC mi
invading the tumors. A quantification of the CD31-positive vessels/field is shown in
(C) and (G), 100 mm. p values are according to Student’s t tests. See also Figure
DevelopmVEC-containing cell-cell contacts. Rok-a in turn mediates the
phosphorylation of MLC2 at the AJ, where it is required for the
homogeneous distribution of VEC at the cell-cell junctions and
for the stabilization of sprouts.
The Regulatory N-Terminal Domain of Raf-1 Is Sufficient
to Rescue the Sprouting Defects
To further explore the function of Raf-1 in sprouting, we trans-
fected Raf-1D/D pMECs with vectors expressing Raf-1 proteins
fused to GFP. Fluorescence-activated cell-sorted GFP-express-
ing cells were used in a 3D sprouting assay. Vector-transfected
clones (eV) performed as poorly as Raf-1D/D pMECs in the
sprouting assay, whereas full-length kinase-competent or
kinase-dead Raf-1 fully rescued sprouting (Figure 4A) and VEC
localization to AJ (Figure 4C). The Raf-1 N-terminal regulatory
domain (NT) also restored sprouting and VEC distribution to
wild-type levels (Figures 4A and 4B). N-terminal regulatory
domain contains an element essential for Raf-1 activation and
membrane recruitment by small G proteins, such as Ras (Ras
binding domain [RBD]); and a Cystein-rich domain (CRD),
which is essential for auto-inhibition and for the interaction
with Rok-a (Niault et al., 2009). A mutation that compromises
Rok-a binding (CC165/168SS; NT CC/SS) failed to rescue
sprouting andVECdelocalization of theRaf-1D/DECs (Figure 4B).
Thus, the ability of Raf-1 to bind to Rok-a, but not Raf-1
kinase activity, is required for efficient sprouting and cell-cell
adhesion. A second Raf-1 mutant (R89L; NT R89L), capable of
binding to Rok-a, but not to Ras (Niault et al., 2009) or Rap1
(Herrmann et al., 1996; Nassar et al., 1996; Nassar et al.,
1995), was similarly ineffective in rescuing the phenotypes
(Figures 4B and 4C), suggesting that G protein binding was
essential for the localization of the Raf-1/Rok-a complex to
VEC-containing junctions.
EPAC Activation Recruits the Raf-1/Rok-a Complex to
VEC-Containing Junctions
Ras is not reported to localize to AJ, and its activation does not
promote AJ formation but rather induces their disassembly to
increase cell motility (Popoff and Geny, 2009). In contrast,
Rap1 is present in VEC-containing junctions (Dejana et al.,
2009) and has been implicated in the formation and tightening
of AJ in both ECs and epithelial cells (Kooistra et al., 2007;
Pannekoek et al., 2009) and in sprouting downstream of FGF
(Yan et al., 2008). Intriguingly, the phenotypes of Raf-1 and
Rap1 knockout ECs partially overlap (Carmona et al., 2009;
Chrzanowska-Wodnicka et al., 2008; Yan et al., 2008).different time points during sprouting are shown. In Raf-1D/D, pMEC cultures
arrow), and eventually undergo apoptosis, as indicated bymembrane blebbing
in gels. Cultures were stained with Rhodamin-phalloidin to visualize F-actin
l, containing FGF-2 and VEGF (1 mg each), was subcutaneously injected into f/f
antibodies (D) or with CD31/DAPI to visualize ECs. In (D), dashed lines indicate
shown in the right panel. Four plugs/genotypewere analyzed; error bars, SD of
aph shows tumor volume and mass assessed 14 days after subcutaneous
ce. In (G), CD31 immunohistochemistry was used to visualize ECs and vessels
the right panel; error bars, SD of themean. Scale bars: (A), (D), and (E), 200 mm;
s S1 and S2 and Movies S1 and S2.
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Figure 2. Raf-1 Affects VEC-Mediated AJ Formation
(A) Rok-a substrates are slightly hyperphosphorylated in continuously growing Raf-1D/D pMECs. Expression of Raf-1, VEC, and Rok-a, and phosphorylation
of Rok-a downstream targets were detected by immunoblotting.
(B and C) VEC fails to localize at cell-cell borders in sprouts formed by Raf-1D/D pMECs in 3D cultures (B) and in matrigel plugs (C). VEC patterns (red) and nuclei
(DAPI, blue) were analyzed by confocal microscopy.
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Essential Role of Raf-1 in Sprouting AngiogenesisIn ECs, Rap1-induced tightening of AJ (Kooistra et al., 2005)
and VEC stabilization at the cell-cell contacts (Noda et al.,
2010) depend on the cAMP-inducible Rap1 GEF (guanine-
nucleotide exchange factor) EPAC. As previously reported
(Wittchen et al., 2005), the cAMP analog 007 [8-(4-chloro-
phenylthio)-20-O-methyladenosine-30,50-cyclic monophosphate]
(Enserink et al., 2002), a selective EPAC activator, accelerated
AJ formation among f/f cells after replating and potently induced
the colocalization of VEC and pMLC2 at nascent junctions.
Both effects were blunted in Raf-1D/D iMECs (Figure 5A); the
lack of junctional myosin activation in Raf-1D/D iMECs correlated
with a failure to remodel the actin cytoskeleton and establish
the cortical actin band, which stabilizes AJ (Figure 5B). The
effects of 007 on AJ maturation and cytoskeletal rearrange-
ments were completely abrogated by a Rok inhibitor, which
phenocopied the situation in Raf-1D/D iMECs (Figure 5C). Thus,
007 increased AJ maturation by a mechanism dependent on
both Raf-1 and Rok.
Consistent with this, both 007 and FGF-2 induced the associ-
ation between Raf-1 and VEC (Figures 6A and 6B). Increased
complex formation was sensitive to GGTi-298, a potent, selec-
tive inhibitor of Rap prenylation (Qian et al., 1998) (Figures 6A
and 6B) and to the compound siRNA-mediated knockdown of
Rap1A and B (Figure 6C). Consistently, Rap1A/B knockdown
(Figure 6D; Figure S4) or Rap inhibition by GGTi-298 (Figure S4)
severely impaired AJ maturation and Rok-a localization to
developing AJs. Similarly, recruitment of Rok-a to the AJ failed
in Raf-1D/D iMECs, indicating that both Rap1 and Raf-1 are
essential for this process (Figures 6D and 6E).
FGF-2 and 007 treatment had hardly any effect on the associ-
ation between Raf-1 and Rok-a, (Figure 6B), suggesting that
they were recruited to VEC as a complex. Rok-b could not be
found in VEC or Raf-1 immunoprecipitates, and did not colocal-
ize with VEC in f/f cells (Figure S4); consistently, siRNA-mediated
knockdown of Rok-a, but not Rok-b, impaired 007-induced AJ
maturation in f/f cells (Figure 6F).
DISCUSSION
Rho-dependent myosin contractility has emerged as a central
regulator of AJ size and strength. In established AJ, increased
contractility correlates with the weakening of the junctions and
with increased endothelial permeability (Dudek and Garcia,
2001; Rolfe et al., 2005). During sprouting, myosin activation
must be tightly controlled because if it happens too fast or is
unduly strong or prolonged, the junctions will not be plastic
enough to allow sprouting (Abraham et al., 2009). On the other
hand, endogenous tugging forces generated locally by Rho/
Rok-dependent myosin activation promote junction growth(D) Delayed formation of VEC-containing AJ and mislocalization of activated my
presence of FGF-2 (50 ng/ml) and fixed at the indicated time points. The localizatio
were stained with DAPI (blue). Note the consistent colocalization of VEC and pML
treated with the Rok inhibitor (20 mM Y-27632). The numbers below the pictures
(E) Rok inhibition does not rescue the sprouting defect of Raf-1D/D pMECs. Y-276
was analyzed as in Figure 1A. Note the increased amount of individual cells sca
A quantification of the results is shown in the right panel (minimum n = 25microcar
been added to two of the images lacking contrast to highlight the profile of the s
according to Student’s t tests. n.s., not significant.
Developm(Liu et al., 2010); if these forces are not timely generated or
they are too weak, the junction’s growth and stabilization will
be delayed. This dual role of myosin activation in junction
plasticity is reflected by the effect of a Rok-inhibitor on sprouting
f/f 3D cultures. Partial inhibition of Rok by low concentrations
of the inhibitor, which reportedly increase Rac1 activity
(Abraham et al., 2009), enhances sprouting; higher concentra-
tions, however, block AJ growth (Liu et al., 2010) and inhibit
sprouting (Figure 2E). Similarly, both accelerating and delaying
AJ maturation by activating or inhibiting Rap1 suppresses
sprouting (Figure S5). The latter treatments phenocopy the
defects of ECs lacking Raf-1; in 3D sprouting assays, the most
obvious consequence of Raf-1 ablation is the formation of cell-
cell contacts that cannot be stabilized fast enough to withstand
the pull of the tip cell, which breaks off the developing sprout
and eventually dies (Figure 1B; Movies S1 and S2). Thus, in
contrast to other cell types and tissues in which Raf-1’s main
role is that of an endogenous Rok-a inhibitor, and in which
chemical or genetic Rok-a inhibition rescues the Raf-1 knock-
out phenotypes (Ehrenreiter et al., 2009; Ehrenreiter et al.,
2005; Niault et al., 2009; Piazzolla et al., 2005), in ECs Raf-1 is
a crucial component of the molecular machinery linking VEC to
Rok-a signaling and myosin activation.
Raf-1 modulates myosin activation at VEC-containing
contacts by bringing Rok-a to these structures. Both kinases
are present in VEC immunoprecipitates from f/f cells treated
with agents that modulate AJ formation, but much less Rok-a
coprecipitates with VEC in Raf-1D/D iMECs, resulting in a
dramatic reduction of activated myosin selectively at AJ (Fig-
ures 2, 3, 5, and 6). The hyperphosphorylation of Rok-a down-
stream targets observed in Raf-1 knock-out MECs (Figure 2A),
albeit subtle, suggests that Raf-1 might in addition function as
an endogenous Rok-a inhibitor, as described in other cell types
(Ehrenreiter et al., 2009; Ehrenreiter et al., 2005; Niault et al.,
2009; Piazzolla et al., 2005). On this basis, it is tempting to
speculate that Raf-1 might both recruit Rok-a to VEC and
dim its activity at the AJ. Such a mechanism would ensure tight
regulation of Rok-a signaling at the AJ, preventing excessive
actomyosin contractility and the generation of centripetal
forces that might ultimately destabilize the AJ. The lack of
phenotype in Raf-1D/D MEC monolayers and in unperturbed
c-raf-1D/DEC adult mice compared with the defects in AJ devel-
opment, sprouting and neovascularization, indicate that the
Raf-1-mediated fine tuning of Rok-a is most important for
AJ plasticity in the course of remodeling processes, rather
than in the AJ maintenance.
How is the complex recruited to AJ? The N-terminal regulatory
domain of Raf-1 is sufficient to rescue the sprouting defects of
Raf-1D/D pMECs, but mutation of either the RBD or the CRD,osin (pMLC) in Raf-1D/D iMECs. iMECs were seeded on chamber slides in the
n of VEC (red) and pMLC (green) was analyzed by confocal microscopy. Nuclei
C in the f/f iMECs and the lack of colocalization in the Raf-1D/D cells or in cells
indicate the percentage of cells positive for junctional pMLC, ± SD.
32 was added to the fibrin gels at indicated concentrations. Sprout formation
ttered around the microcarrier in the f/f cultures treated with 50 mM Y-27632.
riers per genotype and treatment; error bars, SE of the mean). Blue traces have
prouts. Scale bars (B) and (C), 20 mm; (D), 10 mm; and (E), 200 mm. p < 0.001,
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Figure 3. Raf-1 Is Required for the Recruitment of Rok-a to AJ and for Junctional Myosin Activation
(A–C) Growth factors and increasing cell densities induce the recruitment of Raf-1 and Rok-a to VEC. iMECs were treated with FGF-2 or VEGF (both 50 ng/ml) for
30 min (A) or with FGF-2 (50 ng/ml) for the indicated times (B) or seeded at low (LD) or high density (HD) (C). VEC immunoprecipitates were prepared and the
presence of VEC and coimmunoprecipitating proteins was detected by immunoblotting. In (A), the right panel shows growth factor-induced recruitment of Raf-1
to VEC plotted as fold Raf-1-VEC interaction in unstimulated cells (set as 1; mean ± SE of four experiments).
(D) Raf-1 is required for growth factor-stimulated recruitment of Rok-a to VEC. iMECs were treated with FGF-2 or VEGF as in (A). The right panel shows FGF-2
induced recruitment of Rok-a to VEC plotted as fold Rok-a–VEC interaction in unstimulated cells (set as 1; mean ± SE of three experiments). The p value was
calculated by comparing f/f versus Raf-1D/D cells.
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Essential Role of Raf-1 in Sprouting Angiogenesisrequired for the binding of Raf-1 to Rok-a (Niault et al., 2009),
nullifies this effect (Figure 4). Thus, binding to Rok-a and to an
activated G protein is essential for the function of Raf-1 in EC
sprouting. With the exception of K-Ras, which contributes to
the formation of Oncostatin M-induced E-cadherin cell-cell
contacts in hepatocytes (Matsui et al., 2002), Ras activation is
mostly associated with junction disassembly (Popoff and
Geny, 2009). We show that another Ras-like G protein, Rap1,
which is activated at newly formed VEC-containing cell-cell
contacts (Sakurai et al., 2006; Wittchen et al., 2005) and plays
an important role in the extension of nascent contacts in ECs
(Figures 5 and 6) (Kooistra et al., 2005; Noda et al., 2010) and
epithelial cells (Dube´ et al., 2008), but is dispensable for AJ
maintenance (Dube´ et al., 2008; Hogan et al., 2004), is the
upstream regulator of Raf-1 at AJ. Rap1 activation is necessary
and sufficient to recruit Raf-1 and Rok-a to VEC, and Rap1-
induced AJ maturation is blunted in Raf-1D/D iMECs (Figures 5
and 6). Unlike Ras activation in epithelial cells and in the
epidermis (Ehrenreiter et al., 2009; Niault et al., 2009), Rap1 acti-
vation does not promote the association between Raf-1 and
Rok-a. Collectively, therefore, the data are consistent with
a model in which Rap1 activation recruits the Raf-1/Rok-
a complex to VEC to locally regulate MLC2 activity and AJ
dynamics during sprouting.
In contrast to Raf-1, endothelial B-Raf is not required for
sprouting and does not coimmunoprecipitate with VEC under
any of the conditions tested (data not shown). In good correlation
with our model, Rap1 binds more efficiently to Raf-1 than to
B-Raf (Hu et al., 1997; Okada et al., 1999) because of its higher
affinity to the Raf-1 CRD (Okada et al., 1999). The Raf-1 CRD
is also required for Rok-a binding and inhibition (Niault et al.,
2009), and an exhaustive two-hybrid screen for A-Raf and
Raf-1 interactors has identified the CRD as the discriminator
between these two proteins (Yuryev and Wennogle, 2003).
Thus, the CRD has a prominent role in conferring specificity to
Raf isoforms.
EPAC and Rap1 are also crucial regulators of endothelial
permeability (Cullere et al., 2005; Kooistra et al., 2005; Wittchen
et al., 2005; Yan et al., 2008), and the Rap1 effector KRIT1
(CCM1; a member of the cerebral cavernous malformation
family), as well as its interacting protein CCM2, are particularly
important in this context (Glading et al., 2007; Stockton et al.,
2010). Intriguingly, KRIT1 or CCM2-depleted cells show
a dramatic increase in active RhoA and in MLC2 phosphoryla-
tion, particularly at the junctions. This correlates with the desta-
bilization of mature junctions and with vascular leakage, which
can be alleviated by treatment with a Rok inhibitor (Stockton
et al., 2010). On the contrary, Raf-1D/D cells show a selective
lack of MLC2 activation at nascent AJ. This correlates with
defects in junction formation and sprouting, which are phe-
nocopied by treatment of f/f cells with a Rok inhibitor or with(E) pMLC is not associated with AJ in Raf-1D/D iMECs. iMECs were stimulated w
by confocal microscopy. The percentage of cells positive for junctional pMLC (m
(F) Rok-a does not colocalize with VEC in Raf-1D/D iMECs. Rok-a (red) and VEC (gr
Scale bar: 20 mm.
(G) pMLC fails to localize at cell-cell borders in sprouts formed in matrigel plugs
immunoprecipitate using an unrelated, isotype-matched antibody, instead of the
DevelopmsiRNA against Rok-a (Figures 1, 2, 5, and 6). Whether the deple-
tion of KRIT1/CCM2 has any effect on nascent AJ dynamics
has not been investigated; similarly, we currently do not know
whether Raf-1 ablation has an effect on endothelial permeability.
However, the existence of these two pathways, impacting
Rho/Rok signaling at the AJ in opposite ways, would allow for
the fine regulation of AJ plasticity by EPAC/Rap1.
The control of cadherin-containing AJ by EPAC/Rap1 and
myosin is not unique to ECs; epithelial cell junctions are regu-
lated in a similar way (Dube´ et al., 2008; Pannekoek et al.,
2009; Papusheva and Heisenberg, 2010). Preliminary results
indicate that Raf-1 is recruited to E-cadherin and regulates its
distribution to the membrane in the epidermis (R.W. and M.B.,
unpublished data). We are currently determining whether this
function of Raf-1 has an impact on epidermal barrier function.
In keratinocytes, Raf-1 inhibition of Rok-a is required for the
development and maintenance of Ras-dependent tumors
(Ehrenreiter et al., 2009). This is related to Rok-a’s ability to
promote keratinocyte differentiation by inducing EDC expres-
sion (McMullan et al., 2003) and cell cycle exit through the
phosphorylation of other downstream targets, such as cofilin
(Honma et al., 2006). Thus, the consequences of the interaction
of Rok-a with Raf-1 are cell- and context-dependent, but their
net effect is to promote tumorigenesis, either in a cell autono-
mous manner (inhibition of cell differentiation) or by supporting
tumor-driven angiogenesis. Accordingly, approaches targeting
the Raf-1/Rok-a complex may be considered attractive in the
(co)therapy of cancer.
EXPERIMENTAL PROCEDURES
Matrigel Plug Assay and LLC-1 Xenografts
We subcutaneously injected 400 ml Matrigel, high concentration (BD Biosci-
ence) supplemented with 1 mg recombinant human FGF-2 and 500 ng VEGF
(R&D), or 106 LLC-1 cells in 100 ml PBS (Akhtar et al., 2002). Matrigel plugs
were isolated 10 days postinjection and the tumors were isolated 14 days
postinjection. Onset and size of tumors were monitored at least twice
a week. Plugs and tumors were fixed in 4% PFA and subjected to immunohis-
tochemical analysis. Animal experiments were authorized by the Austrian
Ministry of Science and Communications, following the approval by the
national Ethical Committee for Animal Experimentation.
Plasmids
Raf-1 GFP constructs were kindly provided by R.M. Lafrenie. The Raf-1 NT-
CC/SS and Raf-1 NT-R89L were generated by site-directed mutagenesis
(Stratagene) and verified by sequencing.
Histological Analysis
Hematoxylin/eosin staining and immunohistochemistry were performed on
3-mm-thick sections of 4% paraformaldehyde-fixed, paraffin-embedded
tissue. ECs were visualized using a rat-anti-mouse-CD31 antibody (BD
PharMingen) detected with the DAKO EnVision peroxidase system, followed
by incubation with 0.01% diaminobenzidine (Sigma), in conjunction with
avidin-biotinylated enzyme complex (Vector Laboratories) for biotinylated
antibodies. Sections were counterstained with hematoxylin. A secondaryith FGF-2 (50 ng/ml) for 30 min. pMLC (green) and DAPI (blue) were visualized
ean ± SD) is shown in the lower panel.
een) were visualized by confocal microscopy. DAPI was used as a counterstain.
implanted in Raf-1D/DEC mice. Scale bar: 20 mm. In (A), IgG represents control
VEC antibody. In (A)–(D), input = whole cell lysate. See also Figure S3.
ental Cell 22, 158–171, January 17, 2012 ª2012 Elsevier Inc. 165
Figure 4. The N-Terminal Domain of Raf-1
Is Sufficient to Restore Sprouting and Junc-
tional VEC in Raf-1D/D pMECs
(A) Reconstitution of Raf-1D/D pMECs with the
regulatory N-terminal domain restores the number
and length of sprouts formed in 3D fibrin gels.
(B) Raf-1 CRD andRBD are essential for sprouting.
(C) The N-terminal domain of Raf-1, but not
the CRD and RBD mutants, restore junctional
VEC in Raf-1D/D pMECs. f/f and Raf-1D/D pMECs
were transfected with GFP-tagged constructs and
FACS sorted. Sprouting efficiency was assessed
3 days later. The results (number of sprouts/bead
and sprout length) are plotted in the lower panels
(n = number of microcarriers evaluated; error bars,
SE of the mean). Scale bars: (A)–(B), 200 mm; (C),
20 mm. In (B), green traces have been added to
three of the images lacking contrast to highlight
the profile of the sprouts.
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Essential Role of Raf-1 in Sprouting Angiogenesisdonkey-anti-rat-Alexa594 antibody (Invitrogen) was used to visualize CD31-
positive cells by immunofluorescence.
EC Isolation, Culture, Transfection/Sorting, and Immortalization
Endothelial cells were isolated using a modification of an earlier protocol (Lim
and Luscinskas, 2006). Lungs were isolated from 10-day-old mice and placed166 Developmental Cell 22, 158–171, January 17, 2012 ª2012 Elsevier Inc.in cold EC Base Medium (DMEM Medium supple-
mented with nonessential amino acids, 1mM
sodium pyruvate [GIBCO], 25 mM HEPES pH 7.4
[Applichem], penicillin/streptomycin, and 20%
FBS [Sigma]) on ice. The tissue was minced and
enzymatically digested in 1 mg/ml Collagenase
Type 1 (Worthington; 1 hr at 37C). Tissue frag-
ments were resuspended using a syringe with an
18G needle and passed through a cell strainer
(70 mm mesh size; BD Falcon) to obtain a single
cell suspension. Cells were seeded onto 10 cm
cell culture plates (BD Falcon) coated with 2%
gelatin (Sigma) and 10 mg/ml Fibronectin (Roche)
and cultured in EC culture medium (EC Base +
100 mg/ml Endothelial Mitogen [Biomedical Tech-
nologies] and 100 mg/ml Heparin [Sigma]). After
48–72 hr, cells were trypsinized and incubated
with rat anti-mouse ICAM-2 antibody (BD-Phar-
Mingen) coupled to dynabeads (Dynal Biotech;
1 hr at 4C). Cell-coated beads were placed for
2 min in a magnetic particle concentrator (Dynal),
washed four times with 1 ml of EC base, and
seeded on 6 cm plates. The sorting was repeated
once more after the cells reached confluence.
The protocol reproducibly yields 95%–98% pure
MECs.
pMECs were transfected with GFP-tagged
Raf-1 constructs using Lipofectamine Plus (Invi-
trogen), in accordance with the manufacturer’s
protocol. Sixteen to eighteen hours after transfec-
tion, GFP+ pMECs were sorted using a BD FACS
Aria cell sorter, purified up to 95% GFP+ cells,
and left to recover overnight. Sixteen to eighteen
hours later the cells were used in the fibrin gel
bead assay.
Immortalized MECs (iMECs) were derived
from primary ECs incubated with the supernatant
of polyoma middle T antigen-producing cells
(Balconi et al., 2000), supplemented with 8 mg/mlpolybrene to increase infection efficiency. Infection was repeated three times
at 2-day intervals.
For growth factor or 007 (Biolog) stimulation, MECs were incubated in
FBS-reduced base medium (1% FBS) for 16–18 hr prior to treatment with
FGF-2, VEGF, or 007 at the concentration and for the time indicated in the
figure legends.
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Figure 5. EPAC/Rap-Mediated AJ Maturation and Actin Bundle Formation Depends on Raf-1 and Rok-a
(A–C) iMECs were seeded on chamber slides in the presence or absence of 007 (250 mM) and of Y-27632 (20 mM). After 2 hr, the localization of VEC (red) and
pMLC (green) was analyzed by confocal microscopy. DAPI (blue) was used as a counterstain. In (B)–(C), VEC (red) was used to visualize the AJ; filamentous actin
(green) was visualized by phalloidin staining. Note the strong increase in AJ maturation (A) and (C) and peripheral actin bundling induced by 007 in f/f, but not in
Raf-1D/D cells or in Y-27632-treated f/f cells. The graphs in (A) and (C) show the percentage of cells (mean ± SD) containing immature or mature junctions. Scale
bars: 20 mm. See also Figure S3.
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Figure 6. EPAC/Rap Activation Recruits the Raf-1/Rok-a Complex to VEC-Containing AJ
(A and B) iMECs were treated for 30 min with FGF-2 (50 ng/ml) or with the cAMP analog 007 (50 mM), a selective EPAC activator. Where indicated, cells
were pretreated with GGTi-298 (10 mM; 1.5 hr) prior to stimulation to block Rap-dependent signaling. (A) VEC or (B) Raf-1 immunoprecipitates were prepared
and the presence of VEC or Raf-1 and coimmunoprecipitating proteins were detected by immunoblotting.
(C) Rap1A/B is required for EPAC-mediated recruitment of Rok-a and Raf-1 to VEC. iMECS in which Rap1A and Rap1B were knocked down by
siRNA interference, were stimulated with 007 (50 mM, 30 min). The presence of Rok-a and Raf-1 in VEC immunoprecipitates was detected by
immunoblotting.
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Rok-a (L-040429-00-0005), Rok-b (L-046504-00-0005), Rap1A (L-057058-01-
0005), and Rap1B (L-062638-01-0005) were silenced using ON-TARGETplus
SMARTpool siRNAs (Dharmacon). Nontargeting pool (D-001810-10-05) was
used as control. In accordance with the supplier’s protocol, 1 3 105 iMECs
were transfected with 25 nM of the previously mentioned oligos. After 48 hr,
transfection medium was changed to EC base medium. Cells were plated
the next day for experiment.
Fibrin Gel Bead Assay
A previously established assay (Nakatsu et al., 2007) was optimized for
pMECs. Briefly, 2,500 Cytodex beads (GE Healthcare) were incubated with
106 pMECs (5 hr, 37C, and 5% CO2) and plated overnight on a 10 cm dish
to remove unattached cells. Next day, the cell-covered beads were resus-
pended to a concentration of 500/ml in 2 mg/ml fibrinogen (Sigma) solution
containing 0.15 U/ml aprotinin (Sigma), 200 ng/ml FGF-2, and 200 ng/ml
VEGF. Aliquots were mixed with Thrombin (Sigma; 0.625 U/ml), distributed
in 24-well plates (Nunc; 500 ml/well), and left to clot for 5–10 min. After further
incubation (10 min, 37C, and 5% CO2), EC base was added to cover the clot.
Sprout formation was imaged with a Zeiss Axiovert 200M equipped with an
Axiocam MRm and analyzed with the Zeiss Axiovision software. For videomi-
croscopy, clots were imaged for 3 days every 30 min at various Z-positions
using a Zeiss Axiovert 200M equipped with temperature, CO2 and humidity
control and a CoolSnap HQ2 camera. Where indicated, Rok or Rap inhibition
was achieved by adding Y-27632 (Calbiochem) or GGTi298 (Calbiochem) to
the fibrinogen solution.
Immunofluorescence in 3D Fibrin Gels and Whole-Mount
Matrigel Plugs
For VEC staining, samples were fixed (1% PFA in 250 mM HEPES [pH 7.4],
15 min at RT), washed (TBST, 0.2% Tween-20, 15 min) prior to blocking
(0.1% gelatin in PBST, 0.2% Tween, 1 hr at 4C), and incubated with primary
rat anti-mouse VEC antibodies (BD PharMingen; 1:100 in blocking solution,
1 hr at 37C). Samples were washed thrice (30 min with PBST at RT), postfixed
(4% PFA in PBS for 15 min), and washed again (30 min each TBST, PBST,
blocking solution) before incubating with anti-rat-Alexa594 conjugate (1:500
overnight at 4C). Samples were then washed (thrice with PBS and once
with H20, 30 min each) before mounting in DAKO mounting medium. Filamen-
tous actin was detected in samples fixed in 4% PFA for 30min by staining
with phalloidin-Alexa594 (Invitrogen, 1:500 in PBS, 1 hr at RT). Nuclear
chromatin was stained by incubating the samples for 20–30 min in 0.5 mg/ml
DAPI in PBS solution.
Immunofluorescence in 2D Cultures
Cells were permeabilized (0.2% Triton X-100 in PBS, 10 min RT), blocked
(5% skim milk in PBS, 1 hr RT), and washed extensively with PBS prior to
the simultaneous incubation with rat anti-mouse-VEC (BD PharMingen) and
goat anti-mouse-pMLC (Santa Cruz) antibodies (1:100 in 3% BSA, overnight
at 4C). After thorough washing in PBS, cells were stained with the appropriate
secondary antibody (anti-rat-Alexa594, anti-goat-Alexa488, Invitrogen; 1:500
in 5% skim milk, 1 hr at RT), washed in PBS, counterstained with DAPI,
and mounted in DAKO fluorescent mounting medium. The results of the
immunofluorescence experiments were quantified by analyzing at least
100 cells/sample from two independent experiments and are plotted in the
figures as mean ± SD.
Immunoprecipitation and Immunoblotting
Cells were washed once with ice-cold PBS and lysed in IP-buffer (20 mM
Tris/acetate [pH7.0], 0.27 M sucrose, 1% Triton X-100, 1 mM DTT, 1 mM(D) Raf-1 and Rap1 are required for efficient Rok-a recruitment to VEC junctions.
were seeded for 2 hr in the presence or absence of 007 (250 mM). Rok-a (red) and
a counterstain. Note the absence of junctional Rok-a in Raf-1D/D cells and in f/f c
(E) iMECs were treated and VEC immunoprecipitates were analyzed as in (A). In th
a-VEC interaction in unstimulated cells (set as 1; mean ± SE of three experiment
(F) Small interfering RNA (siRNA)-mediated knock down of Rok-a, but not Rok-b a
the presence of 007 (250 mM). VEC (green) and nuclei (DAPI, blue) were visualized
AJ (mean ± SD). Knockdown efficiency is shown by immunoblotting. Scale bars
DevelopmEGTA, 1 mM EDTA, 1 mM Na3VO4, 25 m MNaF, 1 mM PMSF, and protease
inhibitor cocktail [Roche]). We precleared 500 mg clear cell lysate (1 mg
protein/ml) with 40 ml ProteinG-Sepharose beads (Pierce, 1 hr at 4C) and
incubated with the relevant antibodies (rat anti-mouse-VEC 1:100, rabbit
anti-mouse Raf-1, Cell Signaling; 1:100 overnight at 4C). Immunocomplexes
were collected by adding 40 ml protein G-sepharose beads (1 hr at 4C).
For immunoblotting, cell lysates and immunoprecipitates were subjected to
SDS-PAGE and blotted to nitrocellulose membranes subsequently probed
with a-actin, a-14-3-3 a-pMYPT1, a-Rok-a, and a-pCofilin (Santa Cruz);
a-Raf-1, a-a-catenin, a-b-catenin, and a-p120catenin (BD Transduction Labo-
ratories); a-VEC (BD PharMingen); and a-pMLC2 and a-pERK (Cell Signaling).
After incubation with the appropriate secondary antibody, the antigens were
visualized by ECL (Pierce).
Statistical Analysis
p values were calculated with the two-tailed Student’s t test. p % 0.05 is
considered statistically significant.
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